Leerink cuts target for Boston Scientific stock to USD 55.00

Published on 10/13/2026 at 16:49 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Boston Scientific stock faces a USD 55.00 Leerink target after a cut from USD 60.00. The stock costs EUR 38.04 on October 13, 2026.

Target cut and valuation

Leerink Partners lowered its Boston Scientific target from USD 60.00 to USD 55.00, as reported on October 12, 2026.
Boston Scientific's market capitalization was EUR 63.4 billion equivalent in the latest market data, with a P/E ratio of 17.29.
Boston Scientific stock costs EUR 38.04 at Lang & Schwarz on October 13, 2026 at 4:38 p.m. CEST.
The stock's primary-exchange 52-week range was USD 41.39 to USD 105.65.

Aquarell der Bostoner Skyline mit Bürotürmen, die sich im Charles River spiegeln — Boston Properties US1011371077 als aquarellierte Bostoner Skyline mit Bürotürmen am Charles River, Illustration mit AI erstellt.

Leerink Partners cut its Boston Scientific target from USD 60.00 to USD 55.00, as MarketBeat reported on October 12, 2026. Boston Scientific was trading at EUR 38.04 at Lang & Schwarz on October 13, 2026 at 4:38 p.m. CEST.

Target cut sharpens valuation debate

The revised target keeps the analyst view above the current euro quotation, but the currencies are different and no direct percentage comparison is made. The cut itself is the measurable change: Leerink moved its target down by USD 5.00, or 8.33 percent from USD 60.00.

Boston Scientific develops medical devices for cardiovascular care, endoscopy, urology, pelvic health and neuromodulation. Its business is organized around MedSurg, Rhythm and Neuro, and Cardiovascular activities, giving the company exposure to several procedure markets rather than one product category.

Stock remains near its yearly range

The primary-exchange quote was USD 42.67 on October 13, 2026 at 2:48 p.m. UTC, while the 52-week range was USD 41.39 to USD 105.65. The lower end of that range sits USD 1.28 below the latest US quote, while the upper end is USD 62.98 higher.

The euro quotation and the US quotation use different currencies and venues, so the Lang & Schwarz price is presented separately from the NYSE range. The euro price was EUR 38.04 at Lang & Schwarz, with a bid of EUR 38.01 and an ask of EUR 38.08.

Market value and business scale

Boston Scientific had a market capitalization of USD 63.4 billion and a P/E ratio of 17.29 in market data dated October 13, 2026. The company profile lists Healthcare as its sector and Medical - Devices as its industry, with 59,000 full-time employees.

The valuation figures provide a second way to read the target revision. Leerink's USD 55.00 target is USD 5.00 below its earlier USD 60.00 level, while the company continues to operate across multiple interventional medical specialties.

Price and trading context

Boston Scientific was trading at EUR 38.04 at Lang & Schwarz on October 13, 2026 at 4:38 p.m. CEST. The quote's reference close is not used here because the applicable comparison is the dated Xetra close, which was not available as a substantiated value for this report.

The further course of trading is shown by the continuously updated real-time quote of Boston Scientific stock.